been strengthened by several observations showing that growth factors (such as G-CSF, GM-CSF, IL-3 and SCF) modulate the expression or function of several cytoadhesive Transplantation of growth factor-mobilized peripheral blood progenitor cells (PBPC) is widely used in the molecules on the surface of hematopoietic progenitor cells. 8, 9 In addition, cytokines produce profound morphotreatment of several neoplastic diseases. While in PBPC harvests the presence of several accessory immune and logical and immunohistochemical changes in marrow stroma and in the contiguous extracellular matrix.
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been strengthened by several observations showing that growth factors (such as G-CSF, GM-CSF, IL-3 and SCF) modulate the expression or function of several cytoadhesive Transplantation of growth factor-mobilized peripheral blood progenitor cells (PBPC) is widely used in the molecules on the surface of hematopoietic progenitor cells. 8, 9 In addition, cytokines produce profound morphotreatment of several neoplastic diseases. While in PBPC harvests the presence of several accessory immune and logical and immunohistochemical changes in marrow stroma and in the contiguous extracellular matrix. 10, 11 tumor cells has been documented, that of stromal cells has not been reported. In the present study, we investiThese results suggest that marrow stroma should not be impervious to the effect of growth factors during PBPC gated for the presence of stromal cells in growth factormobilized PBPC harvests from breast cancer patients.
mobilization procedures and raise the question of whether stromal cells are released from the marrow and conseLow-density cells from PBCP harvests in culture gave rise to an adherent layer containing fibroblast-like and quently are present in cytokine-mobilized PBPC harvests.
In the present study, we monitored the presence of stromal large flat round cells. These cells express positive immunofluorescence staining for collagen I, collagen III, fibcells in growth factor-mobilized PBPC harvests from breast cancer patients. For this purpose, we used a two-step proronectin, VCAM-1 (CD106), ICAM-1 (CD54) and mesenchymal antigens recognized by monoclonal cedure which includes: (1) Patient population and PBPC collection Keywords: stromal cells; growth factor; PBPC; mobilization; breast cancer Fourteen female patients with histologically proven stage II breast cancer with 10 or more involved axillary lymph nodes, were subjected to PBPC collection after receiving chemotherapy, 6 followed by recombinant human G-CSF Peripheral blood progenitor cells (PBPC) transplantation (Neupogen; Hoffmann-La Roche, Basel, Switzerland) or has become an accepted method for dose intensification in GM-CSF (Leucomax; Schering Plough-Sandoz Pharma, the treatment of several neoplastic diseases.
1,2 Different Basel, Switzerland) at 5 g/kg/day, one day after the end procedures have been used for PBPC mobilization and of chemotherapy. PBPC were collected using a Haemonetremoval from the circulation by apheresis. At present, most ics V50 blood separator (Haemonetics, Braintree, MA, methods exploit the rebound in circulating progenitors that USA) during marrow recovery as soon as a distinct popuoccurs after cytotoxic chemotherapy. 3 In addition, the shortlation of CD34 + cells (у10/l) was detectable in the perterm administration of either GM-CSF or G-CSF enhances ipheral blood. An aliquot of PBPC was used for morphothe yield of PBPC, as measured by the number of CD34 + logical examination and determination of CD34 content by cells, which when used for autografting at у2.5 × 10 6 direct immunofluoresence (see below). Another aliquot was CD34 + /kg recipient, ensures fast hematopoietic recovery. [4] [5] [6] set aside for culturing and phenotypic analysis of stromal Several mechanisms seem to be involved in the growth cells. PBPC harvests were volume-reduced by centrifugfactor-mediated release of marrow progenitor cells. 7 ation, diluted in a mixture of autologous plasma and 10% Among them, it appears that after exposure to G-CSF or DMSO, frozen in a rate-controlled freezer (Cryomed, GM-CSF, adhesion molecules are shed from the surface of Forma Scientific, Marietta, OH, USA) and cryopreserved marrow resident primitive multilineage cells, thereby in the vapour phase of liquid nitrogen until reinfused. allowing them to enter the circulation. 5 Figure 1a ). When examined by phase-contrast microscopy, adherent layer either in situ or after detachment with a solthe core of each colony was predominantly formed by sevution of 0.02% EDTA in phosphate-buffered saline, were eral fibroblast-like cells and by few large flat round cells. used for phenotypic analysis.
Small round cells were also seen dispersed within the colonies ( Figure 1b ). By day 20 of culture, cells had proliferated and tended to form a near continuous layer comprising Phenotypic analysis mainly fibroblast-like cells. At that time, large flat cells were dispersed and represented only a minor population Light-microscopic examination was performed on WrightGiemsa-stained cells either in the culture plate or in cyto-( Figure 1c ).
As revealed by histochemical analysis (not shown), strospin preparations of EDTA-detached cells. Histochemical staining was performed by standard protocols using diagmal cells were positive for ␣-naphthyl butyrate esterase, PAS and acid phosphatase, weakly positive for Sudan nostic kits (Sigma) for Sudan Black, Periodic Acid-Schiff (PAS), ␣-naphthyl butyrate esterase, acid phosphatase and Black and negative for membrane alkaline phosphatase. No significant histochemical differences were observed alkaline phosphatase.
For immunofluorescence studies, cells were processed between fibroblast-like and large flat round cells. The immunological characterization of PBPC-derived with a fixation/permeabilization reagent (Cytoperm; Serotec, Oxford, UK) and labeled with the appropriate free or stromal cells was performed by indirect immunofluorescence, by utilizing a panel of monoclonal antibodies curconjugated monoclonal antibody (see below) and read under ultraviolet illumination at 50 nm with a mercury gas rently used to detect bone marrow stromal cells. The results of these studies are summarized in Table 1 . Similarly, lamp on a Nikon microscope. For flow cytometric analysis, EDTA-detached cells or cells in the apheresis products micrographs showing selected immunofluorescence staining (ie fibronectin, collagen I, ICAM-1, VCAM-1 and meswere stained with either pure, FITC-or PE-conjugated monoclonal antibodies. Nonspecific isotype-matched antienchymal antigen SH2) are shown in Figure 2 . In general, the staining pattern revealed production of extracellular bodies were used to determine background fluorescence. Cells were analyzed on a FACScan flow cytometer (Becton matrix molecules and expression of adhesion ligands. Together, stromal cells which are CD14 − and CD34 − Dickinson, San Jose, CA, USA) and data acquisition was performed with FACScan Lysis II research software. Each express mesenchymal antigens recognized by monoclonal antibodies SH2 and SH3. Without exception, no immunomeasurement included at least 30 000 cells.
The following monoclonal antibodies were used: antiphenotypic differences were observed between fibroblastlike and large flat round cells. CD45-FITC, anti-CD14-PE, anti-CD34-PE were purchased from Becton Dickinson; anti-collagen I, anti-collagen III Small round cells, observed within colonies, proved to be CD45
+ and CD34 − and were not further analyzed. and anti-fibronectin were from Sigma; anti-collagen VI was from Gibco BRL (Grand Island, NY, USA); anti-ICAM-1
Flow cytometric analysis of day 10 stromal cells released from the culture dishes by EDTA treatment indicated that (CD54) and anti-VCAM-1 (CD106) were from R&D Systems (Minneapolis, MN, USA). Control mouse IgG 1 -PE, more than 85% of cells expressed a mesenchymal progenitor cell surface protein, detected by monoclonal antibodies IgG 1 -FITC, IgG 2a -PE and F(ab′) 2 -PE were purchased from Becton Dickinson. Monoclonal antibodies SH2 (IgG 1 ) and SH2 and SH3 (Figure 3a) . Furthermore, the flow cytometric analysis of EDTA-released stromal cells revealed no SH3 (IgG 2b ) were kindly provided by Dr AI Caplan (Case Western Reserve University, Cleveland, OH, USA) and by expression of progenitor or mature hematopoietic cell antigens, such as CD34, CD45 and CD14. Figure 3b shows the Osiris Therapeutics (Baltimore, MD, USA). These antibodies recognize antigens on the cell surface of marrowpattern of staining of EDTA-released bone marrow stromal cells after labeling with antibodies SH2 and SH3. derived mesenchymal progenitor cells, but fail to react with Table 1 Immunofluorescence studies on cultured stromal cells generated from mobilized PBPC harvests + cells per harvest and the type of growth factor (GM-CSF or G-CSF) used to mobilize PBPC.
Next, we analyzed whether the efficiency of PBPC mobilization (measured as amount of CD34 + cells collected) correlated with the amount of SH2 + cells detected per apheresis. As seen in Figure 4 , we found a good correlation (r = 0.92, P Ͻ 0.001) between the number of CD34 + cells and that of SH2 + stromal cells. These results suggest that SH2 + cell number could be predicted with a high level of confidence from the number of CD34 + cells collected. Mononuclear cells prepared from the blood of three normal donors did not generate stromal cells in culture, while mononuclear cells from a blood sample taken from a non-breast cancer patient (after 5 days of stimulation with G-CSF), contained 0.11% of SH2 + stromal cells. phenotypic studies have revealed the complexity of phenotypes involved in the formation of intact stromal layers both in short-and long-term cultures of human bone marrow.
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Quantitation of stromal cells in PBPC harvests mobilized To our knowledge, there is no information available on the by growth factors presence of stromal cells in growth factor-mobilized PBPC harvests, 19 whereas the presence of hematopoietic progeniThe content of stromal cells in growth factor-mobilized PBPC harvests was measured by flow cytometry using tors, accessory immune and tumor cells has been well documented. presence of stromal cells in growth factor-mobilized PBPC from breast cancer patients. This includes: (1) the ex vivo generation of stromal cell cultures and their in situ phenotypic characterization and, (2) the direct detection and quantification of stromal cells in PBPC harvests. Analogous approaches have been followed to characterize bone marrow-derived stromal cells exhibiting properties of mesenchymal precursors. [23] [24] [25] Low-density mononuclear cells from PBPC products, ID ONLY COLOUR ARTWORK when cultured in the presence of FCS, give rise to a population of strongly adherent cells. The morphology of these cells revealed two main components: fibroblast-like cells, generally bipolar and with a capacity to proliferate to confluence (more than 20 days of culture) and large flat round cells, whose number decreases as cultures age.
Primary cultures (day 10) of PBPC-derived stromal cells are positive for ␣-naphthyl butyrate esterase, PAS and acid phosphatase and show a weak or negative expression for Sudan Black and alkaline phosphatase, respectively. Early or late myeloid progenitor antigens, such as CD34, CD45, CD14 are not expressed by these cells. On the other hand, PBPC-derived stromal cells express surface antigens which are recognized by antibodies SH2 and SH3, which have been used to characterize bone marrow-derived mesenchy-ID ONLY COLOUR ARTWORK mal cells. 12, 15 Moreover, our studies demonstrate that the complex pattern of extracellular matrix formation exhibited by bone marrow derived-stromal cells 18,26 is also exhibited by PBPC-derived stromal cells. Thus, together with the production of collagen (I, III and VI) and fibronectin, PBPCderived stromal cells express the adhesive ligands VCAM-1 and ICAM-1. These ligands are used by stromal cells to interact with marrow hematopoietic progenitors. 9, 27 Taken together, these results strongly suggest that the adherent layer of cultures generated from PBPC harvests contains stromal cells exhibiting characteristics often assigned to bone marrow-derived stromal cells.
Large flat round cells, one of the two distinct morphological types of cells detected in PBPC cultures, exhibit certain morphological and histochemical features, which ID ONLY COLOUR ARTWORK suggest a monocyte/macrophage nature. However, the these cells to differentiate into a number of distinct stromal cell types has been well established.
14,23-25 Mesenchymal precursors, which are generated under culture conditions including nothing else but 10-20% FCS, once in the presence of differentiation agents develop into cells that among other characteristics, express alkaline phosphatase activity.
24,28
Quantitation of stromal cells in the growth factor-mobilized apheresis products of 11 patients shows that SH2 + /CD14 − cells account for a median of 0.63% (range 0.02-2.32). In this manner, assuming a conservative mean of 3 × 10 8 nucleated cells/kg collected by leukapheresis, a single leukapheresis would be sufficient to accumulate an average of 1.9 × 10 6 /kg stromal cells. Whether the reinfusion of PBPC harvests containing such an amount of stromal cells may contribute to enhancing bone marrow microenvironmental function or hematopoietic reconstitution is not known. In an attempt to investigate the therapeutic significance of bone marrow-derived stromal cells, 
